The news roundup for the week ending 21 July 2016.
Big deal: PureLifi radiates $9.2m series B
The Edinburgh spinout, which uses LED light to wirelessly transmit data, has attracted series B capital from a consortium led by Temasek, the investment arm of Singapore’s government.
Alphabet Energy goes from B to C round
The waste heat-to-energy technology developer has raised $23.5m in a series C round led by Schlumberger and backed by GM Ventures.
Precision Ocular adjusts series A to $20.6m
VIB-affiliated V-Bio Ventures has joined a series A round for the retinal treatment developer that already included Imperial Innovations.
StartX seals Civil Maps partnership at seed stage
Civil Maps, a startup working on autonomous car mapping technology, has raised $6.6m in a seed round that will fund product development.
Immago journeys to Hansa Medical
Oxford spinout Immago Biosystems, which is working on increasing the efficiency of antibody-based cancer therapies, has been acquired by Hansa Medical.
Celgene chimes in for $57m Oncorus series A
Celgene has supported a funding round for Oncorus, an immuno-oncology treatment developer exploiting research conducted at Pittsburgh.
NZ to attract researchers with $25m
Auckland has launched an initiative aimed at bringing renowned researchers to the country, with the government providing $25m in funding.
Reflexion shows $52m for series B round
Johnson & Johnson invested $6m to help radiotherapy equipment developer Reflexion Medical close out its Pfizer-backed series B round at $52m.
Stanford supports Launchpad cohort
Six startups have entered the Launchpad Digital Health accelerator and secured funding supplied from investors including Stanford University and the institution’s StartX.
The Global University Venturing Deal Net rounds up all the latest smaller deals and tracks emerging companies accessing university funds.
